Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing
Abstract Background Aging, noise, infection, and ototoxic drugs are the major causes of human acquired sensorineural hearing loss, but treatment options are limited. CRISPR/Cas9 technology has tremendous potential to become a new therapeutic modality for acquired non-inherited sensorineural hearing...
Main Authors: | Xi Gu, Daqi Wang, Zhijiao Xu, Jinghan Wang, Luo Guo, Renjie Chai, Genglin Li, Yilai Shu, Huawei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Genome Biology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13059-021-02311-4 |
Similar Items
-
Specific knockdown of Htra2 by CRISPR-CasRx prevents acquired sensorineural hearing loss in mice
by: Yang Guo, et al.
Published: (2022-06-01) -
HTRA2/OMI-Mediated Mitochondrial Quality Control Alters Macrophage Polarization Affecting Systemic Chronic Inflammation
by: Qingqing Liu, et al.
Published: (2024-01-01) -
Overview of Human HtrA Family Proteases and Their Distinctive Physiological Roles and Unique Involvement in Diseases, Especially Cancer and Pregnancy Complications
by: Yao Wang, et al.
Published: (2021-10-01) -
The role of Omi/HtrA2 protease in neonatal postasphyxial serum-induced apoptosis in human kidney proximal tubule cells
by: Zhang Yong, et al.
Published: (2012-01-01) -
Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy
by: Pengfei Wang, et al.
Published: (2018-10-01)